ArticleTherapeutic advances in neurological disorders2026

Natalizumab for pediatric multiple sclerosis: a systematic review and meta-analysis.

Yasin Ebne-Ali-Heydari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.